Analysis of the common CFHR3-1 deletion demonstrated its association with protection in AMD being present in a total of 32.8% of controls compared to 13.75% of cases (p = 2.38×10−12) OR = 0.31, CI-0.95 (0.23–0.44) (Table 2). Here, CFHR3 is linked to age-related macular degeneration.